At a glance
(thousands of €, if not stated otherwise) |
Year ended 31 December 2020 |
Year ended 31 December 2019 |
Year ended 31 December 2018 |
||||||
INCOME STATEMENT (**) |
|
|
|
||||||
Revenues |
478,053 |
834,901 |
278,666 |
||||||
Other income |
52,207 |
50,896 |
29,000 |
||||||
R&D expenditure |
(523,667) |
(420,090) |
(316,222) |
||||||
S, G&A expenses |
(185,225) |
(96,959) |
(38,523) |
||||||
Operating expenses |
(708,892) |
(517,049) |
(354,746) |
||||||
Operating profit/loss (-) |
(178,632) |
368,748 |
(47,080) |
||||||
Net financial results |
(131,143) |
(220,223) |
15,662 |
||||||
Taxes |
(1,226) |
165 |
(822) |
||||||
Net profit/loss (-) from continuing operations |
(311,001) |
148,689 |
(32,240) |
||||||
Net profit from discontinued operations, net of tax |
5,565 |
1,156 |
2,981 |
||||||
Net profit/loss (-) |
(305,436) |
149,845 |
(29,259) |
||||||
|
|
|
|
||||||
BALANCE SHEET |
|
|
|
||||||
Cash and cash equivalents |
2,135,187 |
1,861,616 |
1,290,796 |
||||||
Current financial investments |
3,026,278 |
3,919,216 |
- |
||||||
R&D incentives receivables |
135,728 |
115,356 |
84,646 |
||||||
Assets |
5,717,731 |
6,068,609 |
1,439,496 |
||||||
Shareholders' equity |
2,670,355 |
2,875,658 |
1,214,249 |
||||||
Deferred income |
2,809,133 |
3,000,646 |
149,801 |
||||||
Other liabilities |
238,242 |
192,305 |
75,446 |
||||||
|
|
|
|
||||||
CASH FLOW |
|
|
|
||||||
Operational cash flow/operational cash burn (-) (*) |
(517,404) |
3,162,809 |
(158,384) |
||||||
Cash flow generated/used (-) in operating activities |
(427,336) |
3,208,617 |
(142,466) |
||||||
Cash flow generated/used (-) in investing activities |
757,288 |
(3,764,660) |
(15,914) |
||||||
Cash flow generated in financing activities |
22,040 |
1,335,751 |
287,876 |
||||||
Increase in cash and cash equivalents |
351,994 |
779,708 |
129,497 |
||||||
Transfer to current financial investments |
- |
(198,922) |
- |
||||||
Effect of currency exchange rate fluctuation on cash and cash equivalents |
(70,539) |
(9,966) |
10,089 |
||||||
Cash and cash equivalents on 31 December |
2,143,071 |
1,861,616 |
1,290,796 |
||||||
|
|
|
|
||||||
Cash and cash equivalents from continuing operations |
2,135,187 |
1,861,616 |
1,290,796 |
||||||
Cash and cash equivalents classified as assets held for sale |
7,884 |
- |
- |
||||||
Current financial investments on 31 December |
3,026,278 |
3,919,216 |
- |
||||||
Total current financial investments and cash and cash equivalents on 31 December |
5,169,349 |
5,780,832 |
1,290,796 |
||||||
FINANCIAL RATIOS |
|
|
|
||||||
Number of shares issued on 31 December |
65,411,767 |
64,666,802 |
54,465,421 |
||||||
Basic income/loss (-) per share (in €) |
(4.69) |
2.60 |
(0.56) |
||||||
Diluted income/loss (-) per share (in €) |
(4.69) |
2.49 |
(0.56) |
||||||
Share price on 31 December (in €) |
80.48 |
186.50 |
80.56 |
||||||
Total group employees on 31 December (number) (***) |
1,489 |
1,003 |
725 |
||||||
|
|||||||||
Employees per site
Number of employees Galapagos group
Total number of employees includes 185 employees from Fidelta, which was sold to Selvita on 4 January 2021, and includes consultants and temporary staff